ImYoo operates in the health technology sector, focusing on personalized health interventions through single cell gene expression profiling. The company serves individuals seeking to understand their immune variability and connect with others who have similar immune system profiles. ImYoo's core service involves analyzing thousands of genes in thousands of cells from a single blood sample, enabling out-of-clinic human immunity studies. The business model includes offering self-collection blood kits that users can ship for analysis, and generating revenue through subscription-based services and partnerships with healthcare providers. ImYoo aims to deliver biology-driven health interventions by matching users based on their gene expression data, facilitating shared health journeys and intervention tracking for chronic symptoms. The company is currently seeking beta users, study participants, and advocates to further develop its technology.

Keywords: single cell profiling, immune variability, gene expression, personalized health, user matching, chronic symptom tracking, health technology, self-collection kits, out-of-clinic studies, biology-driven interventions.